SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-144519
Filing Date
2020-05-18
Accepted
2020-05-18 07:30:56
Documents
6
Period of Report
2020-05-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d901612d8k.htm 8-K 28778
2 EX-10.1 d901612dex101.htm EX-10.1 9966
3 EX-10.2 d901612dex102.htm EX-10.2 32599
4 EX-99.1 d901612dex991.htm EX-99.1 10726
5 GRAPHIC g901612ex101.jpg GRAPHIC 4655
6 GRAPHIC g901612g68d10.jpg GRAPHIC 4039
  Complete submission text file 0001193125-20-144519.txt   95563
Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38137 | Film No.: 20888074
SIC: 2834 Pharmaceutical Preparations